Dual blockade of CSF1 and IL34 was slightly more efficacious at preventing disease in DSS colitis than the monotherapies, reducing the histology score compared to the control treatment but was less efficacious than the treatment with CSA, which reduced the histology score by >50%. The gene discussed is CSF1; the disease is colitis.